Find Academic Supervisors

Matthias GriederView profile

Research Fellow

• Neuroimaging
• Anxiety Disorders
• Addiction Disorders
• +7 more

Matthias Grieder is a Research Fellow at the Medical Faculty of the University of Bern, affiliated with the Translational Research Center of the University Hospital of Psychiatry and Psychotherapy Bern. He holds a PhD in Neurosciences (2012) and completed a habilitation in Psychiatric Neurosciences (2023). His work bridges psychiatric neuroimaging, memory research, and neuromodulation techniques like tDCS. Education: PhD in Neurosciences (2012), University of Bern Habilitation in Psychiatric Neurosciences (2023), University of Bern Research interests include: Neuroimaging of anxiety and addiction disorders Semantic memory processing in aging and dementia Structural/functional connectivity of memory networks Non-invasive brain stimulation (tDCS) for memory enhancement Sleep-dependent memory consolidation in psychiatric populations Recent publications focus on 7T MRI, fractal complexity analysis, and amygdala-frontal connectivity in addiction and anxiety. Collaborations span institutions like the University Hospital of Psychiatry Bern, IOS Press, and Springer Nature. Laboratory affiliations include the Translational Research Center at the University Hospital of Psychiatry and Psychotherapy Bern, where he leads studies on neuroimaging biomarkers for psychiatric diseases.

Anna-Katharine BremView profile

Lecturer

• Neuroscience
• Psychiatry
• Cognitive Science
• +3 more

Anna-Katharine Brem is a **Lecturer and Group Leader** at the **University Hospital of Old Age Psychiatry and Psychotherapy**, University of Bern, Switzerland. Her research focuses on cognitive and functional improvement in dementia and depression through noninvasive brain stimulation, cognitive training, and remote technologies. She holds a Ph.D. in Neuroscience from the University of Zurich and has held roles at institutions like Harvard Medical School and King’s College London. Research Interests: Her work integrates clinical psychiatry with neurotechnology, emphasizing translational approaches to neurodegenerative and mental disorders. Key areas include: Non-invasive brain stimulation therapies Remote monitoring for Alzheimer’s disease Cognitive enhancement in aging populations Neurophysiological markers of mental health Collaborations: Partners with institutions such as King’s College London, Harvard Medical School, and the Max Planck Institute of Psychiatry. Articles Trends: Recent work explores digital health solutions (e.g., wearable devices, AR diagnostics) and neuromodulation for Alzheimer’s and depression, with a focus on clinical translation and accessibility challenges. Grants & Advising: Leads interdisciplinary teams in clinical trials and technology development. Advises on policy for neurotechnology applications in aging populations. Labs/Teams: Directs the **Research Group Brem**, focused on bridging clinical neuroscience and innovative therapies.

Marina WunderlinView profile

Research Fellow

• Sleep Medicine
• Mental Health
• Neuroscience
• +3 more

Dr. Marina Wunderlin is a Postdoc researcher at the University Clinics UPD Bern, affiliated with the Department of Old Age Psychiatry and Psychotherapy. She holds a PhD (2022), MSc (2017), and BSc (2015) in Psychology from the University of Bern. Her research focuses on sleep physiology, mental health, and aging, particularly exploring sleep’s role in dementia prevention and cognitive function. She investigates non-invasive brain stimulation techniques and their impact on sleep modulation, as well as cognitive behavioral therapy for insomnia in psychiatric comorbidities. Her work integrates neuroscientific and clinical methodologies, emphasizing translational research to improve mental health outcomes in aging populations. Key contributions include systematic reviews on sleep interventions and their effects on memory and amyloid dynamics. She collaborates with multidisciplinary teams at UPD and international institutions, advancing understanding of sleep oscillations and their disruption in neurodegenerative disorders.

• Neuroscience
• Psychiatry
• Cognitive Remediation
• +4 more

Leonie Bais is a researcher specializing in neuroscience and psychiatry, with a focus on non-invasive brain stimulation techniques for severe mental illness. Her work explores the integration of cognitive remediation with transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS) in clinical settings. Key Research Areas: Schizophrenia, apathy, cognitive impairment, transcranial magnetic stimulation, transcranial direct current stimulation, mental illness treatment. Her recent publications include randomized controlled trials (RCTs) and systematic reviews analyzing the efficacy of combined cognitive and neurostimulation interventions. Collaborations span institutions like the University of Groningen (via co-authors) and multicenter psychiatric networks. Notable Trends: Emphasis on transdiagnostic approaches, patient acceptability, and long-term clinical implementation of neurostimulation technologies.

• Parkinson's Disease
• Movement Disorders
• Dystonia Therapeutics
• +4 more

Mark Floyd Lew is Professor of Clinical Neurology and Vice Chair of Neurology at USC's Keck School of Medicine. He holds the Joseph P. Van Der Meulen Chair in Parkinson's Disease Research and serves as Division Chief of Movement Disorders. His clinical research focuses on Parkinson's disease therapeutics, dystonia management, and novel treatments for movement disorders. Dr. Lew has an international reputation for developing innovative treatments, including advanced apomorphine delivery systems and botulinum toxin applications. He collaborates with advocacy organizations like the Hollyrod Foundation to support Parkinson's research and awareness. Research Focus: Key research areas include: Motor fluctuation management in Parkinson's disease Botulinum toxin formulations for dystonia and sialorrhea Non-invasive neuromodulation for tremor control Biomarker discovery in tear fluid Gut-brain axis in neurodegeneration Recent clinical trials explore continuous drug delivery systems, novel botulinum toxin formulations, and inhaled levodopa. His biomarker research demonstrates the diagnostic potential of tear fluid analysis for Parkinson's detection. Clinical Translation: As a clinical trialist, Dr. Lew has contributed to FDA approvals for Parkinson's treatments. His work informs clinical guidelines for titration protocols and therapeutic timing. Current projects include mitochondrial dysfunction in neurodegeneration and home-based neuromodulation devices. He maintains an active clinical practice while conducting trials through USC's Parkinson's research programs.

• Neurorestoration
• Brain-Computer Interfaces
• Deep Brain Stimulation
• +5 more

Charles Yu Liu is a Clinical Professor at the University of Southern California (USC) with appointments in Neurosurgery, Psychiatry and the Behavioral Sciences, Surgery, and Biomedical Engineering via the Viterbi School of Engineering. He serves as Director of the USC Neurorestoration Center and Surgical Director of the USC Comprehensive Epilepsy Program, a global leader in surgical epilepsy treatment. Undergraduate: Chemical Engineering, University of Michigan, Ann Arbor PhD: Chemical/Biomedical Engineering, Rice University MD: Yale University School of Medicine Liu specializes in neurorestoration, focusing on restoring function to injured nervous systems through advanced neurosurgical tools and brain-computer interfaces. His research integrates neuroscience, biomedical engineering, and clinical neurosurgery to address epilepsy, stroke recovery, and neuromodulation therapies. His 15 most recent publications (2025-2024) span Biomedical Engineering , Neuroscience , and Neurology , with subfields including neural interfaces, beta-band oscillations, neuroprosthetics, and neuroimaging. Key themes involve decoding motor and cognitive neural signals, improving deep brain stimulation parameters, and exploring SARS-CoV-2 neurotropism. Liu chairs the Department of Neurosurgery at Rancho Los Amigos National Rehabilitation Center and collaborates with institutions like Caltech. He serves as Associate Editor of World Neurosurgery and consults for the NCAA USC Trojans Athletics Department on neurosurgical safety.

• Clinical Epilepsy
• Neuromodulation
• Neurophysiology
• +5 more

Ryan McGinn is an Assistant Professor of Clinical Neurology at the University of Southern California (USC). His academic journey spans diverse fields: beginning as a professional jazz musician, he transitioned to study physics and neural engineering at the University of Toronto before completing medical training at McMaster University and epilepsy fellowships at Stanford University. He currently focuses on clinical epilepsy, emphasizing advanced treatments like epilepsy surgery, neuromodulation (e.g., thalamic and cortical stimulation), and network-based interventions. Dr. McGinn's research integrates quantitative sciences with medicine, particularly in understanding seizure states and connectivity through signal processing of intracranial recordings. His work addresses cutting-edge topics such as thalamic involvement in refractory epilepsy, fasciola cinereum as an interventional target, and touch-screen automatisms in the digital era. His contributions include systematic reviews on stereotactic biopsies and mesenchymal stem cell therapies for stroke, reflecting his commitment to bridging preclinical and clinical research. His publications span over two decades, demonstrating expertise in epilepsy mechanisms, neurophysiology, and translational neuroscience. His early work explored thermoregulation in diabetes and exercise physiology, reflecting his interdisciplinary background. Collaborative efforts in neuroengineering and precision medicine underscore his vision for personalized neurological care. No specific scientific awards or grants are highlighted in the profile, though his extensive publication record indicates sustained research activity. His educational background in both music and physics uniquely informs his approach to understanding complex neurological patterns and rhythms.

• Sports Medicine
• Interventional Spine Care
• Regenerative Medicine
• +3 more

Gene Tekmyster, DO, is a Clinical Assistant Professor in the Department of Orthopaedic Surgery at the University of Southern California's Keck School of Medicine. Double board-certified in Physical Medicine & Rehabilitation and Sports Medicine, he specializes in non-operative management of spinal disorders, regenerative treatments, and advanced interventional spine care. Dr. Tekmyster serves as physician consultant for the Los Angeles Kings (NHL) and USC Trojans Athletics, and as team physician for U.S. Ski & Snowboard teams. His research focuses on regenerative therapeutics for chronic low back pain, spinal stenosis management, and optimizing function recovery. Clinical interests include: Interventional spine procedures Regenerative medicine applications Sports injury rehabilitation Minimally invasive pain management Publications demonstrate sustained focus on spine intervention safety (anticoagulant management), innovative pain therapies (epidural steroids, spinal cord stimulators), sports-related injuries, and telehealth applications in rehabilitation. Recent work emphasizes real-world device outcomes and procedural optimization. Honors & Leadership: Section Editor for MSK/Pain/Spine, Journal of Osteopathic Medicine (2024) Chair of Patient Safety Committee, North American Spine Society (2023) SpineLine 20 under 40 Award, North American Spine Society (2021) Dr. Tekmyster contributes to national spine research initiatives and has implemented new technologies for treating spinal conditions at Keck Medicine. He holds coaching certifications in weightlifting and strength training, aligning with his clinical emphasis on functional restoration.

• Transcranial Magnetic Stimulation
• Neuroscience
• Clinical Psychology
• +2 more

Chris P.J. Baeken is a University Researcher in the Department of Electrical Engineering at Eindhoven University of Technology, specializing in neuromodulation techniques and clinical neuroscience. His research focuses on developing and optimizing non-invasive brain stimulation methods for psychiatric disorders, particularly treatment-resistant depression. Research interests include: Transcranial Magnetic Stimulation (TMS) protocols Neurophysiological mechanisms of depression Brain network connectivity analysis Neuroimaging techniques Cognitive and affective neuroscience Recent publications demonstrate a strong focus on clinical applications of neuromodulation, particularly exploring accelerated stimulation protocols and their effects on treatment-resistant populations. Research frequently incorporates multimodal approaches combining neurostimulation with functional imaging. Collaborates extensively with clinical institutions internationally and contributes to understanding brain-behavior relationships through innovative stimulation paradigms.

Franka GlöcknerView profile

Researcher

• Cognitive Neuroscience
• Aging and Cognition
• Decision-Making
• +4 more

Dr. Franka Glöckner is a Postdoctoral Researcher at the Department of Psychology, Technische Universität Dresden. She specializes in cognitive neuroscience, aging research, and decision-making processes. Her work focuses on neuroplasticity, neuromodulation (e.g., dopamine effects), and interventions targeting cognitive decline in older adults. She leads initiatives in good scientific practice and advises international applicants for the Cognitive-Affective Neuroscience (CAN) Master's program. Her research explores how environmental factors, pharmacological agents (e.g., levodopa), and brain stimulation (e.g., galvanic vestibular stimulation) influence decision-making, memory, and spatial navigation across the lifespan. Recent studies investigate the neural correlates of interventions in dementia care and the role of circadian rhythms in cognitive performance. Dr. Glöckner is actively involved in clinical trials like the TRAINSTIM-COG project, examining combined cognitive training and brain stimulation effects on aging populations. She advocates for accessibility, serving as faculty representative for disabled students and coordinating student internships.

Kelly BertramView profile

Research Fellow

• Parkinson's disease
• Atypical Parkinsonism
• Dystonia
• +3 more

Kelly Bertram is a Senior Research Fellow in the Department of Neuroscience at Monash University and a Clinical Neurologist at Alfred Hospital. Specializing in Movement Disorders, their research focuses on Parkinson's disease, Atypical Parkinsonism (including Progressive Supranuclear Palsy and Multiple System Atrophy), and Dystonia. They contribute to UN Sustainable Development Goals through neurodegenerative disease research. Education: MBBS from the University of Melbourne. Current projects include clinical trials for treatments targeting Spinocerebellar Ataxia Type 2, Parkinson’s disease symptom management, and disease-modifying therapies for PSP. Recent work includes developing diagnostic protocols for atypical parkinsonian syndromes and investigating non-invasive brain stimulation effects on cognitive function in Parkinson’s patients. No scientific awards are explicitly listed in the provided text. Advising and grants: Lead investigator in multiple clinical trials and research projects since 2016, including sodium selenate trials and drug efficacy studies. Collaborates widely on neurodegenerative disease research. Labs/teams: Affiliated with Monash University’s Movement Disorders research group, contributing to translational studies and clinical protocols.

James CoxonView profile

Associate Professor

• Neuroscience
• Exercise Physiology
• Cognitive Neuroscience
• +5 more

James Coxon is an Associate Professor at Monash University's School of Psychological Sciences and an ARC Future Fellow. He is based at the Turner Institute for Brain and Mental Health and leads the Movement and Exercise Neuroscience Laboratory (MEXlab). His research focuses on understanding how exercise impacts brain plasticity, learning, and cognition, particularly in aging populations and neurological conditions. He holds a PhD in Human Movement Neuroscience from the University of Auckland and postdoctoral experience at KU Leuven, Belgium. Affiliations: Turner Institute for Brain and Mental Health, Victorian Heart Institute (VHI) Education: PhD in Human Movement Neuroscience (2007), University of Auckland; BSc (Hons) in Exercise Science (2003), University of Auckland Research interests span exercise physiology, movement neurophysiology, and cognitive neuroscience, with a focus on non-invasive brain stimulation techniques (EEG, MRI). Key goals include developing exercise-based interventions to promote healthy brain aging and improve symptoms in neurological disorders. Recent publications highlight the role of dopamine receptors, cortical inhibition, and high-intensity exercise in motor skill acquisition and memory consolidation. His work contributes to UN Sustainable Development Goals related to health and well-being. Grants: ARC-funded projects on motor skill learning and NHMRC grants for neural circuit dynamics research Editorial Roles: Editorial board member for Experimental Brain Research and The Journal of Physiology MEXlab collaborates internationally to investigate exercise-brain interactions, with a focus on translational research for clinical applications.

Paul FitzgeraldView profile

Adjunct Professor

• Psychiatry
• Neuroscience
• Brain Stimulation Therapies
• +3 more

Professor Paul Fitzgerald is an Adjunct Professor (Research) in the Department of Psychiatry at Monash University and Director of the Epworth Centre for Innovation in Mental Health. He holds dual roles as Professor of Psychiatry at Monash University and Epworth HealthCare. With a medical degree (1991) and PhD in transcranial magnetic stimulation (2003), his research focuses on developing brain stimulation therapies for psychiatric disorders like depression, schizophrenia, and Alzheimer’s disease. Key techniques include rTMS, tDCS, and DBS. He has led over 48 research projects, secured $15M+ in funding, and published over 500 peer-reviewed articles. Awards include NARSAD Young Investigator Awards (2003/2005) and RANZCP Senior Research Award (2022). Education: MBBS (Monash, 1991), Masters of Psychological Medicine (1998), PhD in Psychiatry (2003) Research Interests: Neurostimulation therapies, neuropsychiatric disorders, neuroimaging, clinical trial development His work bridges clinical translation and device innovation, involving collaborations with biomedical engineers and industry partners. Notable contributions include the first TMS training program in Australia and over 10 clinical TMS services established. Current projects include Alzheimer’s trials and brain stimulation device advancements. Awards highlight his impact in neuropsychiatry, including pioneering work in rTMS for treatment-resistant depression. He chairs the Monash Instrumentation Facility and holds 4 patents in neurotechnology. Editorial roles include deputy editor of Brain Stimulation , reflecting his global leadership in the field. His research also explores meditation’s neurophysiological effects and psychedelic therapies.

Miodrag BolićView profile

Associate Professor

• Computer Architectures
• Signal Processing
• Wireless Communications
• +3 more

Miodrag Bolić serves as Associate Professor at the School of Information Technology and Engineering (SITE), University of Ottawa, Canada, holding this position since 2009 after serving as Assistant Professor from 2004-2009. His academic credentials include Ph.D., M.Sc., and B.Sc. degrees. His research integrates computer engineering with biomedical applications across four core domains: Computer Architectures (focusing on architectural parallelization, interpreted language support, and multiprocessor systems); Signal Processing (specializing in biomedical signal analysis); Wireless Communications (centered on RFID systems); and Biomedical Engineering (targeting non-invasive brain stimulation and blood pressure measurement technologies). This interdisciplinary approach bridges hardware innovation with real-world healthcare solutions. Dr. Bolić co-founded Astraion LLC in 2007 and currently directs two research entities: the Computer Architecture Research Lab (CARG) and RFID Research Group at SITE. These labs drive collaborative projects between academia and industry, with his leadership emphasizing practical implementations of theoretical frameworks in embedded systems and sensor networks.

Jason StumhoferView profile

Associate Professor

• Immunology
• Infectious Diseases
• Vaccine Development
• +3 more

Dr. Jason Stumhofer is an Associate Professor in the Department of Microbiology and Immunology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. His research focuses on understanding immune responses to Plasmodium parasites, particularly mechanisms underlying protective immunity against malaria. He holds a Ph.D. from Drexel University College of Medicine and completed postdoctoral training at the University of Pennsylvania School of Veterinary Medicine. Research interests include: Generation and maintenance of protective antibody responses Role of germinal centers in B cell maturation CD4+ T cell differentiation (Th1, Tfh) Stromal cell regulation of humoral immunity Impact of cytokines like IL-17 and ICOS co-stimulation Key findings include identification of B cell progenitors supporting antibody production during malaria and the regulatory role of ICOS signaling in T cell differentiation. His lab uses murine models (Plasmodium yoelii, P. chabaudi) to study splenic immune dynamics. Collaborative work has advanced photoacoustic imaging techniques for malaria diagnosis. Publications (selected highlights): Defined IL-17's role in B lineage development during infection Characterized ICOS's dual role in T helper cell differentiation Identified NK1.1+ CD4+ T cell subsets supporting early antibody responses Pioneered photoacoustic flow cytometry for malaria detection